Lakefront Biotherapeutics | GLPG - Dochód Netto





Dochód Netto Zmiana Data
argenx SE USD 472M 106M 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Biogen USD 97.5M 222M 2026-06
Genmab DKK 303M 250M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
GRIFOLS EUR 154M 81M 2026-06
Hikma Pharmaceutical USD 164M 45M 2025-12
Incyte USD 585.6M 282.27M 2026-06
Merck EUR 490M 169M 2026-06
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Novartis USD 3.26B 108M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 343M 1.27B 2026-06
UCB EUR 1.08B 608M 2025-12
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06